Parkinson disease (PD) is common in long term care (LTC) facilities. The number of institutionalized patients with PD will rise sharply in the coming decades because of 2 concurrent phenomena: aging of the population leads to an increased PD prevalence and improved quality of care has led to a prolonged su...
“Parkinson’s Disease and Psychosis in the Post-Acute and Long-Term Care Setting” is a new pocket guide developed by geriatricians, neurologists, and movement disorder specialists from Post-Acute and Long-Term Care Medical Association (PALTmed). The guide includes an extensive glossary to clarify terminolog...
This package includes the Parkinson’s Disease Clinical Practice Guideline, and the Parkinson’s Disease & Psychosis in PALTC Pocket Guide.
Parkinson’s disease (PD) is a progressive, neurodegenerative movement disorder. While there is no known treatment, the symptoms can be controlled with medication,...
Parkinson's disease (PD) is a common condition among older people and requires tailored, time-sensitive pharmacologic therapy for optimal symptom management. No prior studies have examined the extent to which doses of time-critical PD medicines are delayed or missed in residential aged care (RAC) sett...
With the aging population, community-based activities promoting social connections are increasingly encouraged internationally to delay functional decline. In Japan, “community gathering places” are municipally supported for disability prevention. However, whether participation in such programs reduces lon...